CompanyMedical Device

NMPA Approves 172 Medical Devices for Marketing in November 2022

CompanyDrug

Merck’s Lagevrio Receives Emergency Conditional Approval from China’s NMPA

Policy / Regulatory

NHSA and CNIPA Issue Opinions on Strengthening IP Protection in Drug Procurement

CompanyDrug

Legend Biotech’s Carvykti Accepted for Review by China’s CDE

CompanyDeals

F-star Therapeutics and Sino Biopharmaceutical Face Delays in Proposed Acquisition

CompanyDrug

CSPC’s ALMB-0168 Receives NMPA Approval for Osteoarthritis Clinical Study

CompanyDrug

RemeGen’s RC108 Receives FDA Go-Ahead for Phase I Clinical Study

CompanyDrug

Simcere Receives NMPA Clearance for SIM0348 Clinical Study

CompanyDeals

Skynor Medical Raises RMB 100 Million in Financing Round for Market Expansion

CompanyDeals

Sichuan Kelun Completes RMB 1.5 Billion Financing Round for Kelun-Biotech

CompanyDrug

Everest Medicines’ Nefecon Receives Priority Review Recommendation from CDE

CompanyDrug

BrightGene Receives NMPA Approval for BGM0504 Clinical Trial